摘要
利用生理药物动力学模型,对对硝基酚钠在大鼠及人体内的动力学进行研究,结果大鼠模型预报值与实验结果基本一致,人体模型中肾脏与肝脏的最高浓度预报值为大鼠模型的1.5和1.7倍。探讨了以生理药物动力学模型对化学物质进行安全性评价的可能性。
The safety and toxicity of chemicals given first to animals and finally to humans are gen-erally estimated with a method of safe coefficient,which lacks scientific ground.To changethe traditional method,we designed a physiologically based pharmacokinetics model(PBPK)for the estimation of safety and toxicity of chemicals.For example,ρ-nitrophenol sodium(PNP-Na)was used.The PNP-Na pharmacokinetics in bodies of rat as well as humans werestudied,and possibilities of making use of the model in the estimation of safety and toxicity0fChemica15 were also discussed.
出处
《中国医学科学院学报》
CAS
CSCD
北大核心
1996年第5期358-362,共5页
Acta Academiae Medicinae Sinicae
基金
1994年日本国厚生省食品卫生调查研究课题
关键词
药物动力学
对硝基酚钠
安全性
动物模型
physiologically based pharmacokinetics model
ρ-nitrophenol sodium
estimation of safety of chemical